Pub. Date : 2007 Dec
PMID : 18065490
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Flavopiridol suppressed c-FLIP-l/s and BCL-xL expression, whereas vorinostat reduced expression of BCL-xL, and combined exposure to flavopiridol and vorinostat reduced MCL-1 and X-chromosome-linked inhibitor of apoptosis protein (XIAP) levels. | alvocidib | BCL2 like 1 | Homo sapiens |
2 | Flavopiridol suppressed c-FLIP-l/s and BCL-xL expression, whereas vorinostat reduced expression of BCL-xL, and combined exposure to flavopiridol and vorinostat reduced MCL-1 and X-chromosome-linked inhibitor of apoptosis protein (XIAP) levels. | alvocidib | BCL2 like 1 | Homo sapiens |
3 | Flavopiridol suppressed extracellular signal-regulated kinase 1/2 (ERK1/2) and AKT activity and expression of activated forms of AKT and mitogen-activated protein/ERK kinase 1 maintained c-FLIP-l/s, BCL-xL, and XIAP expression and protected cells against flavopiridol/vorinostat lethality. | alvocidib | BCL2 like 1 | Homo sapiens |
4 | Overexpression of c-FLIP-s and BCL-xL abolished the lethality of flavopiridol/vorinostat. | alvocidib | BCL2 like 1 | Homo sapiens |